These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 16373959

  • 1. Pharmaceutical expenditure compared across countries.
    van Mosseveld C.
    Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959
    [Abstract] [Full Text] [Related]

  • 2. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract] [Full Text] [Related]

  • 3. Pharmaceutical expenditure, total health-care expenditure and GDP.
    Clemente J, Marcuello C, Montañés A.
    Health Econ; 2008 Oct; 17(10):1187-206. PubMed ID: 18050150
    [Abstract] [Full Text] [Related]

  • 4. How much do we spend on prescription medicines? Out-of-pocket costs for patients in Australia and other OECD countries.
    Kemp A, Preen DB, Glover J, Semmens J, Roughead EE.
    Aust Health Rev; 2011 Aug; 35(3):341-9. PubMed ID: 21871197
    [Abstract] [Full Text] [Related]

  • 5. Pharmaceutical expenditure and therapeutic value of new medicines in Spain.
    Darba J.
    Pharmacoeconomics; 2003 Aug; 21(16):1211-2. PubMed ID: 14594440
    [No Abstract] [Full Text] [Related]

  • 6. The cost and availability of prescription drugs--what can we do in Massachusetts?
    Carpenter NW, Kedikoglou S.
    Issue Brief (Mass Health Policy Forum); 1999 May 12; (4):1-41. PubMed ID: 12769091
    [No Abstract] [Full Text] [Related]

  • 7. European prices of newly launched reimbursable pharmaceuticals--a pilot study.
    Martikainen J, Kivi I, Linnosmaa I.
    Health Policy; 2005 Nov 12; 74(3):235-46. PubMed ID: 16226136
    [Abstract] [Full Text] [Related]

  • 8. [Proposal on reviewing the overall healthcare expenditure and its allocation: focusing on medication expenses].
    Takamuku M.
    Nihon Geka Gakkai Zasshi; 2010 May 12; 111(3):189-94. PubMed ID: 20540336
    [No Abstract] [Full Text] [Related]

  • 9. Drug costs can be defended.
    Lee AM.
    Med Mark Media; 1982 Mar 12; 17(3):36, 38, 40 passim. PubMed ID: 10309584
    [No Abstract] [Full Text] [Related]

  • 10. Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.
    Moken MC.
    Am J Law Med; 2003 Mar 12; 29(4):525-42. PubMed ID: 15119247
    [No Abstract] [Full Text] [Related]

  • 11. Prescription drug pricing: the consumer perspective.
    Searing A.
    N C Med J; 2003 Mar 12; 64(6):300-2. PubMed ID: 14983625
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prescription drugs: the facts about Canada.
    Consum Rep; 2005 Oct 12; 70(10):50-1. PubMed ID: 16163821
    [No Abstract] [Full Text] [Related]

  • 14. The European value-pricing game.
    McGuire A.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb 12; 12(1):5-6. PubMed ID: 22280188
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Seizures of Canadian drugs rise as Congress, Customs spar.
    Carreyrou J.
    Wall St J (East Ed); 2006 Jul 24; ():B1, B8. PubMed ID: 16909501
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.